"ファイザー" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonHow Pfizer's CEO says he uses AI to make decisions - CNN
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skept...
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics Yahoo Finance
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth - CNBC
Pfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell ...
Pfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell engager Fierce Biotech
Pfizer's Albert Bourla on mega-merger prospects: 'No' - Endpoints News
Pfizer's Albert Bourla on mega-merger prospects: 'No' Endpoints News
After Vyndamax boost, Pfizer marks 2029 for next growth chapter - FirstWord Pharma
After Vyndamax boost, Pfizer marks 2029 for next growth chapter FirstWord Pharma
Pfizer beats estimates but investors cautious - The Pharma Letter
Pfizer beats estimates but investors cautious The Pharma Letter
Pfizer pins post 2028 return to growth on new obesity and cancer drugs - Reuters
Pfizer pins post 2028 return to growth on new obesity and cancer drugs Reuters
Can Pfizer Stock Outrun A $17B Revenue Void? - Trefis
Pfizer Beats Earnings Estimates. The Drugmaker Is Finding Life After Covid. - Barron's
Pfizer Beats Earnings Estimates. The Drugmaker Is Finding Life After Covid. Barron's
Pfizer School of Science Mobile Experience: Inspiring the Next Generation of Innovators - Pfizer
Pfizer School of Science Mobile Experience: Inspiring the Next Generation of Innovators Pfizer
Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality - Fierce Pharma
Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality Fierce Pharma
Inside the Pfizer CentreOne OSD Network - Contract Pharma
Inside the Pfizer CentreOne OSD Network Contract Pharma
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skept...
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics The Motley Fool
Pfizer is a 2029 story but Q126 lays foundation for growth - BioSpace
Pfizer is a 2029 story but Q126 lays foundation for growth BioSpace
Judge Knocks Out Pfizer Partner's Vax Case Against GSK - Law360
Judge Knocks Out Pfizer Partner's Vax Case Against GSK Law360
Is Pfizer Stock Worth Buying After a Q1 2026 Beat and Patent Win? - TIKR.com
Is Pfizer Stock Worth Buying After a Q1 2026 Beat and Patent Win? TIKR.com
Pfizer Tops Sales Estimates as Older Blockbusters Outperform - Bloomberg.com
Pfizer Tops Sales Estimates as Older Blockbusters Outperform Bloomberg.com
Pfizer Climbing Out of COVID-19 Revenue Declines Pegs Growth to Oncology Products, R&D - Precisio...
Pfizer Climbing Out of COVID-19 Revenue Declines Pegs Growth to Oncology Products, R&D Precision Medicine Online
How Pfizer’s Q1 Beat, Oncology Wins and Patent Deals At Pfizer (PFE) Has Changed Its Investment S...
How Pfizer’s Q1 Beat, Oncology Wins and Patent Deals At Pfizer (PFE) Has Changed Its Investment Story Yahoo Finance
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance - Business Wire
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance Business Wire
The Stars Come Out for Pfizer-Sponsored “Divas Simply Singing!” Benefit Concert - Pfizer
The Stars Come Out for Pfizer-Sponsored “Divas Simply Singing!” Benefit Concert Pfizer
FDA clears Pfizer, Arvinas’ novel breast cancer therapy despite mixed data - BioSpace
FDA clears Pfizer, Arvinas’ novel breast cancer therapy despite mixed data BioSpace
Pfizer, Lilly, more report Q1, FDA names acting CBER director and an ALS awakening - BioSpace
Pfizer, Lilly, more report Q1, FDA names acting CBER director and an ALS awakening BioSpace
Pfizer stays the course for 2026 guidance, dulling impact of Q1 earnings beat - BioSpace
Pfizer stays the course for 2026 guidance, dulling impact of Q1 earnings beat BioSpace
Pfizer tops sales estimates as older blockbusters outperform - Crain's New York Business
Pfizer tops sales estimates as older blockbusters outperform Crain's New York Business
Pfizer Earnings: Strong First-Quarter Performance Makes 2026 Guidance More Achievable - Morningstar
Pfizer Earnings: Strong First-Quarter Performance Makes 2026 Guidance More Achievable Morningstar
Pfizer Oncology Advances Raise New Questions For Valuation And Momentum - Yahoo Finance
Pfizer Oncology Advances Raise New Questions For Valuation And Momentum Yahoo Finance
AMD and Pfizer earnings, job openings, Fedspeak: What to Watch - Yahoo Finance
AMD and Pfizer earnings, job openings, Fedspeak: What to Watch Yahoo Finance
Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff...
Not Quite Out of the Woods: Risk for Lyme Disease Prevails in Suburban Environments - Pfizer
Not Quite Out of the Woods: Risk for Lyme Disease Prevails in Suburban Environments Pfizer
Earnings call transcript: Pfizer Q1 2026 beats estimates, stock rises - Investing.com
Earnings call transcript: Pfizer Q1 2026 beats estimates, stock rises Investing.com
Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skeptics - Investor's Business Daily
Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skeptics Investor's Business Daily
Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth - Yahoo Finance
Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth Yahoo Finance
Fact Check: Document Does NOT Show Hantavirus As A COVID-19 Vaccine Side Effect -- It Lists Healt...
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say Yahoo Finance
Pfizer’s newer medicines carry more weight in Q1 - thestreet.com
Pfizer’s newer medicines carry more weight in Q1 thestreet.com
Spotlight On: Pfizer sees China as opportunity to close gap on obesity front-runners - FirstWord ...
Spotlight On: Pfizer sees China as opportunity to close gap on obesity front-runners FirstWord Pharma
A Look At Pfizer (NYSE:PFE) Valuation After Q1 2026 Beat And Pipeline Progress - Yahoo Finance
A Look At Pfizer (NYSE:PFE) Valuation After Q1 2026 Beat And Pipeline Progress Yahoo Finance
Pfizer Earnings: What To Look For From PFE - Yahoo Finance
Pfizer Earnings: What To Look For From PFE Yahoo Finance
Pfizer tops Q1 estimates, maintains guidance (PFE:NYSE) - Seeking Alpha
Pfizer tops Q1 estimates, maintains guidance (PFE:NYSE) Seeking Alpha
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q1 CY2026 - Yahoo Finance
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q1 CY2026 Yahoo Finance
Pfizer Stock Gains Ground Following Better Than Expected Q1 Financial Results - TIKR.com
Pfizer Stock Gains Ground Following Better Than Expected Q1 Financial Results TIKR.com
Pfizer’s Next Lyme Shot: What a Fifth-Dose VLA15 Trial Signals for PFE Investors - TipRanks
Pfizer’s Next Lyme Shot: What a Fifth-Dose VLA15 Trial Signals for PFE Investors TipRanks
Pfizer Q1 Earnings Review: Stuck In Second Gear, But Dividend Helps (NYSE:PFE) - Seeking Alpha
Pfizer Q1 Earnings Review: Stuck In Second Gear, But Dividend Helps (NYSE:PFE) Seeking Alpha
Pfizer, Arvinas join SERD club with Veppanu approval - pharmaphorum
Pfizer, Arvinas join SERD club with Veppanu approval pharmaphorum
Pfizer Stock: Still Priced Like It's Dead Money - The Motley Fool
Pfizer Stock: Still Priced Like It's Dead Money The Motley Fool
Somewhere, someplace, his father must be smiling - The Island News
Somewhere, someplace, his father must be smiling The Island News
Is It Time To Reconsider Pfizer (PFE) After Recent Share Price Rebound? - simplywall.st
Is It Time To Reconsider Pfizer (PFE) After Recent Share Price Rebound? simplywall.st
Pfizer reports Q1 results above consensus, reaffirms 2026 guidance - Sherwood News
Pfizer reports Q1 results above consensus, reaffirms 2026 guidance Sherwood News
US FDA approves Pfizer, Arvinas' breast cancer drug - Reuters
Pfizer Q1 Earnings Beat: Should You Finally Buy PFE as Pharma Play? - Gotrade
Pfizer Q1 Earnings Beat: Should You Finally Buy PFE as Pharma Play? Gotrade
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - Yahoo Finance
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era Yahoo Finance
Guardant Health gets FDA nod for new Pfizer, Arvinas breast cancer drug - FirstWord Pharma
Guardant Health gets FDA nod for new Pfizer, Arvinas breast cancer drug FirstWord Pharma
Cancer Treatments Propel Pfizer Sales Growth as Covid Revenue Dwindles - Yahoo Finance
Cancer Treatments Propel Pfizer Sales Growth as Covid Revenue Dwindles Yahoo Finance
Argus Research Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $35 - Moomoo
Argus Research Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $35 Moomoo
Watch Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC - Bloomberg.com
Watch Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC Bloomberg.com
Pfizer Stock: Still Priced Like It's Dead Money - Yahoo Finance
Pfizer Stock: Still Priced Like It's Dead Money Yahoo Finance
Pfizer’s First PROTAC Approval Adds New Dimension To Oncology Story - simplywall.st
Pfizer’s First PROTAC Approval Adds New Dimension To Oncology Story simplywall.st
Pfizer: Q1 Earnings Snapshot - KTVB
Pfizer CEO Warns China Is Fast Catching Up in Biotech Innovation - Association of American Univer...
Pfizer CEO Warns China Is Fast Catching Up in Biotech Innovation Association of American Universities (AAU)
Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest - NAI500
Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest NAI500
Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth - Zacks Investment Research
Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth Zacks Investment Research
Pfizer Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:PFE) 2026-05-05 - Seeking Alpha
Pfizer Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:PFE) 2026-05-05 Seeking Alpha
Two UConn Pharmaceutical Sciences Ph.D. Students Receive Pfizer Fellowship - UConn Today
Two UConn Pharmaceutical Sciences Ph.D. Students Receive Pfizer Fellowship UConn Today
Tunica-Biloxi Tribe receives grant from Pfizer to expand healthcare in Central Louisiana - KLFY.com
Tunica-Biloxi Tribe receives grant from Pfizer to expand healthcare in Central Louisiana KLFY.com
Pfizer vs. Amgen: Which Big Pharma Stock Is the Better Value Right Now? - TIKR.com
Pfizer vs. Amgen: Which Big Pharma Stock Is the Better Value Right Now? TIKR.com
Pfizer CEO Sees CDC Director Pick Restoring Agency’s Credibility - Bloomberg.com
Pfizer CEO Sees CDC Director Pick Restoring Agency’s Credibility Bloomberg.com
Pfizer tops Q1 expectations on growth from newer products - Yahoo Finance
Pfizer tops Q1 expectations on growth from newer products Yahoo Finance
Pfizer Ends Early-Stage Lymphoma Combo Trial, Trimming a Small Piece of Its Oncology Upside - Tip...
Pfizer Ends Early-Stage Lymphoma Combo Trial, Trimming a Small Piece of Its Oncology Upside TipRanks
Pfizer beats Q1 revenue and profit estimates, reaffirms 2026 guidance - Proactive financial news
Pfizer beats Q1 revenue and profit estimates, reaffirms 2026 guidance Proactive financial news
Pfizer, IQVIA and others beat Q1 forecasts but guidance mixed - MSN
Pfizer, IQVIA and others beat Q1 forecasts but guidance mixed MSN
Pfizer cuts final Trillium-related program, but R&D spend jumps on cancer, obesity studies - Endp...
Pfizer cuts final Trillium-related program, but R&D spend jumps on cancer, obesity studies Endpoints News
Pfizer Q1 Revenue Rises 5% Despite Decline in Covid Products - thelec.net
Pfizer Q1 Revenue Rises 5% Despite Decline in Covid Products thelec.net
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend - Yahoo Finance
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend Yahoo Finance
BofA raises Pfizer stock price target on first-quarter beat - Investing.com
BofA raises Pfizer stock price target on first-quarter beat Investing.com
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View - Benzinga
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View Benzinga
Pfizer Q1 2026 earnings beat estimates on newer drug growth - Yahoo Finance
Pfizer Q1 2026 earnings beat estimates on newer drug growth Yahoo Finance
AI in Healthcare? Pfizer, Anthropic, and Longevity Scientists Think It’s Critical - Yahoo Finance
AI in Healthcare? Pfizer, Anthropic, and Longevity Scientists Think It’s Critical Yahoo Finance
Pfizer tops Q1 estimates, maintains guidance - MSN
Hikma reaches settlement agreement with Pfizer for generic Vyndamax - Drug Store News
Hikma reaches settlement agreement with Pfizer for generic Vyndamax Drug Store News
Pfizer beats first quarter estimates on strong product growth - Investing.com
Pfizer beats first quarter estimates on strong product growth Investing.com
Pfizer earnings in focus as investors eye pipeline, patent cliff By Investing.com - Investing.com
Pfizer earnings in focus as investors eye pipeline, patent cliff By Investing.com Investing.com
FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype - Fierce Pharma
FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype Fierce Pharma
Pfizer beats Q1 expectations, but COVID sales disappoint - medwatch.com
Pfizer beats Q1 expectations, but COVID sales disappoint medwatch.com
Novavax, Inc. Stock Jumps: Why Pfizer’s Matrix-M Deal Drove a Surprise Q1 Revenue Beat - TechStock²
Novavax, Inc. Stock Jumps: Why Pfizer’s Matrix-M Deal Drove a Surprise Q1 Revenue Beat TechStock²
Pfizer stock edges higher as earnings and revenue beat estimates - MSN
Pfizer stock edges higher as earnings and revenue beat estimates MSN
How Pfizer Is resetting its pipeline in oncology and obesity after COVID - Labiotech.eu
How Pfizer Is resetting its pipeline in oncology and obesity after COVID Labiotech.eu
FDA nod for Arvinas and Pfizer’s Veppanu - The Pharma Letter
FDA nod for Arvinas and Pfizer’s Veppanu The Pharma Letter
2 Trendlines in Focus For Pfizer Stock After Earnings - Schaeffer's Investment Research
2 Trendlines in Focus For Pfizer Stock After Earnings Schaeffer's Investment Research
Pfizer tops Q1 expectations on growth from newer products - MSN
Pfizer tops Q1 expectations on growth from newer products MSN
Pfizer Quarterly Results Announcement: Revenue Forecasts and Market Sentiment | May 2026 - News a...
Novavax (NVAX) Finds a New Revenue Engine in Pfizer Licensing - AlphaStreet
Novavax (NVAX) Finds a New Revenue Engine in Pfizer Licensing AlphaStreet
Pfizer Options Spot-On: On May 7th, 299.38K Contracts Were Traded, With 2.62 Million Open Interes...
Pfizer Options Spot-On: On May 7th, 299.38K Contracts Were Traded, With 2.62 Million Open Interest 富途牛牛
How a vet & a lawyer became CEOs of Pfizer & Accenture - Modern Ghana
How a vet & a lawyer became CEOs of Pfizer & Accenture Modern Ghana
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings - Benzinga
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings Benzinga
Pfizer Q1 2026 slides: beats estimates on acquired assets strength - Investing.com
Pfizer Q1 2026 slides: beats estimates on acquired assets strength Investing.com
PFE Earnings: Pfizer Stock Rises on Q1 Beat despite Lower 2026 Sales Outlook - TipRanks
PFE Earnings: Pfizer Stock Rises on Q1 Beat despite Lower 2026 Sales Outlook TipRanks